Dramatic ibrutinib efficacy in Schnitzler syndrome with indolent lymphoma

Claves F, et al.

J Clin Immunol · 2021

Grade Ccase reportn=1
DOI ↗PubMed ↗

Key Findings

  • ●Dramatic ibrutinib efficacy in Schnitzler syndrome with indolent lymphoma

Referenced in (1 disease)

Schnitzler Syndrome
ID: pmid-33871787DOI: 10.1007/s10875-021-01048-0PMID: 33871787